{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:25:48Z","timestamp":1790717148935,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Coronary atherosclerotic heart disease is an important, worldwide burden on human health. Central muscle infarction is the most dangerous condition, has the highest mortality and disability rates, and is gradually becoming more common among young people. After myocardial infarction, neutrophils recruited to the infarcted area promote the myocardial inflammatory response by releasing proinflammatory factors and chemokines and release matrix metalloproteinases and myeloperoxidases that degrade the extracellular matrix and produce reactive oxygen species, resulting in irreversible myocardial damage and thereby promoting ventricular remodeling. In this study, we constructed a mouse model of myocardial infarction and utilized the CXCR2 receptor inhibitor navarixin (Nav) to reduce neutrophil recruitment after MI. We observed that Nav improved cardiac function, reduced myocardial damage, reduced neutrophil infiltration, reduced inflammatory factor expression and improved cardiac fibrosis in mice. Through transcriptomic analysis, we found that Nav affects signaling pathways such as the innate immune response and the chemokine signaling pathway, thereby decreasing the inflammatory response by reducing neutrophil chemotaxis. This study provides new insights for the use of CXCR2 inhibitors as new therapeutic options for myocardial infarction in the future.<\/jats:p>","DOI":"10.3389\/fphar.2025.1535703","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:04:11Z","timestamp":1741849451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory response"],"prefix":"10.3389","volume":"16","author":[{"given":"Peikun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ajpath.2020.12.013","article-title":"Administration of a CXC chemokine receptor 2 (CXCR2) antagonist, SCH527123, together with oseltamivir suppresses NETosis and protects mice from lethal influenza and piglets from swine-influenza infection","volume":"191","author":"Ashar","year":"2021","journal-title":"Am. J. Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.intimp.2012.04.008","article-title":"LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2","volume":"13","author":"Aul","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1227589","DOI":"10.3389\/fcvm.2023.1227589","article-title":"Prevention by the CXCR2 antagonist SCH527123 of the calcification of porcine heart valve cusps implanted subcutaneously in rats","volume":"10","author":"Chabry","year":"2023","journal-title":"Front. Cardiovasc Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/jpet.106.119040","article-title":"A novel, orally active CXCR1\/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation","volume":"322","author":"Chapman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4062\/biomolther.2023.005","article-title":"Megakaryocyte-derived IL-8 acts as a paracrine factor for prostate cancer aggressiveness through CXCR2 activation and antagonistic AR downregulation","volume":"31","author":"Dahal","year":"2023","journal-title":"Biomol. Ther. Seoul."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","article-title":"Mechanical complications of acute myocardial infarction: a scientific statement from the American heart association","volume":"144","author":"Damluji","year":"2021","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"109816","DOI":"10.1016\/j.cellsig.2020.109816","article-title":"Neutrophil signaling during myocardial infarction wound repair","volume":"77","author":"Daseke","year":"2021","journal-title":"Cell. Signal."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1093\/cvr\/cvad117","article-title":"Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2","volume":"119","author":"Dhayni","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"726153","DOI":"10.3389\/fimmu.2022.726153","article-title":"Hypoxia promotes neutrophil survival after acute myocardial infarction","volume":"13","author":"D\u00f6lling","year":"2022","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamacardio.2020.3690","article-title":"Mechanical complications of acute myocardial infarction: a review","volume":"6","author":"Gong","year":"2021","journal-title":"JAMA Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1124\/jpet.106.118927","article-title":"Pharmacological characterization of Sch527123, a potent allosteric CXCR1\/CXCR2 antagonist","volume":"322","author":"Gonsiorek","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cyto.2015.01.002","article-title":"The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects","volume":"72","author":"Hastrup","year":"2015","journal-title":"Cytokine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1183\/09031936.00048509","article-title":"SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects","volume":"35","author":"Holz","year":"2010","journal-title":"Eur. Respir. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/eurheartj\/ehw002","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur. Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e151268","DOI":"10.1172\/JCI151268","article-title":"Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction","volume":"132","author":"Jiang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"9034695","DOI":"10.1155\/2018\/9034695","article-title":"Effect of CXCR2 inhibition on behavioral outcomes and pathology in rat model of neuromyelitis optica","volume":"2018","author":"Jones","year":"2018","journal-title":"J. Immunol. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.112.201855","article-title":"Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1\/CXCR2","volume":"347","author":"Kaur","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/adt.2013.553","article-title":"Phenotypic analysis of chemokine-driven actin reorganization in primary human neutrophils","volume":"12","author":"Kredel","year":"2014","journal-title":"Assay. Drug Dev. Technol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1744806917730212","DOI":"10.1177\/1744806917730212","article-title":"The chemokine receptor CXCR2 supports nociceptive sensitization after traumatic brain injury","volume":"13","author":"Liang","year":"2017","journal-title":"Mol. Pain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/s41591-023-02513-2","article-title":"A new clinical classification of acute myocardial infarction","volume":"29","author":"Lindahl","year":"2023","journal-title":"Nat. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","article-title":"Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial","volume":"42","author":"Nair","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/ijms22020722","article-title":"Neutrophil elastase deficiency ameliorates myocardial injury post myocardial infarction in mice","volume":"22","author":"Ogura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pupt.2015.08.002","article-title":"Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation","volume":"34","author":"Planagum\u00e0","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.jacc.2022.04.015","article-title":"Causes, angiographic characteristics, and management of premature myocardial infarction: JACC state-of-the-art review","volume":"79","author":"Rallidis","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","article-title":"CXCR2 antagonist MK-7123. A phase 2 proof-of-concept trial for chronic obstructive pulmonary disease","volume":"191","author":"Rennard","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.119.043833","article-title":"Neutrophil-derived S100a8\/A9 amplify granulopoiesis after myocardial infarction","volume":"141","author":"Sreejit","year":"2020","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.121.056019","article-title":"Retention of the NLRP3 inflammasome-primed neutrophils in the bone marrow is essential for myocardial infarction-induced granulopoiesis","volume":"145","author":"Sreejit","year":"2022","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pupt.2016.09.005","article-title":"The effects of a CXCR1\/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects","volume":"41","author":"Todd","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIRCRESAHA.120.317200","article-title":"Dynamics of cardiac neutrophil diversity in murine myocardial infarction","volume":"127","author":"Vafadarnejad","year":"2020","journal-title":"Circ. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1038\/s41467-022-33631-z","article-title":"Dusp6 deficiency attenuates neutrophil-mediated cardiac damage in the acute inflammatory phase of myocardial infarction","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1535703\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:04:13Z","timestamp":1741849453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1535703\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":32,"alternative-id":["10.3389\/fphar.2025.1535703"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1535703","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"article-number":"1535703"}}